Home/Investors/Founders

Founders

Biotech Investor · 8 portfolio companies

Portfolio

8

Combined Value

$19.6M

Focus Areas

18

Top Stage

Pre-clinical

Investment Focus

Oncology Infectious Disease Critical Care Women's Health Major Depressive Disorder Treatment-Resistant Depression Spinal Cord Injury Traumatic Brain Injury Urology Gastroenterology Neurology Ophthalmology Glaucoma Retinal Diseases Myopia

Portfolio Companies

Company	Stage	Valuation	Focus
Citius Pharmaceuticals	Approved (Commercial)	$19.6M	Oncology, Infectious Disease
CrossBay Medical	Commercial	—	Women's Health
Mapreg	Phase 2	—	Major Depressive Disorder, Treatment-Resistant Depression
OmniCyte	Pre-clinical	—	Oncology
Dignify Therapeutics	Pre-clinical	—	Urology, Gastroenterology
Amorphex Therapeutics	Pre-clinical	—	Ophthalmology, Glaucoma
Neuronasal	Pre-clinical	—	Neurology, Traumatology
MipSalus	Pre-clinical	—	Metabolic Disorders, Rare Diseases

Frequent Co-Investors

Angel investors1 shared RA Capital Management1 shared Private Investors1 shared Management1 shared Business Angels/Family Offices1 shared Institutional Investors1 shared GENERALI FR (main shareholder)1 shared Connecticut Innovations1 shared